DAVID MANGOLD: Open Payments
NPI 1164533618 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$55 in 3 payments from 2 companies in 2025. Trend: 2023 $671 · 2024 $1,030 · 2025 $55
Food & beverage: $55
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $15 |
Products named: NEFFY, DUPIXENT.
Industry payments across MT — which companies pay providers there.
